P911 Financial Statements From 2010 to 2024
| P911 Stock | 57.98 0.84 1.47% |
Check Dr Ing financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Ing's main balance sheet or income statement drivers, such as , as well as many indicators such as . P911 financial statements analysis is a perfect complement when working with Dr Ing Valuation or Volatility modules.
P911 |
Dr Ing hcF Company Profit Margin Analysis
Dr Ing's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Dr Ing Profit Margin | 0.14 % |
Most of Dr Ing's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Ing hcF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Dr Ing hcF has a Profit Margin of 0.1366%. This is 94.58% lower than that of the Consumer Cyclical sector and 88.52% lower than that of the Auto Manufacturers industry. The profit margin for all Germany stocks is 110.76% lower than that of the firm.
Dr Ing hcF Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.Dr Ing hcF is considered to be number one stock in profit margin category among its peers. It also is considered to be number one stock in operating margin category among its peers reporting about 1.45 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.About Dr Ing Financial Statements
Dr Ing stakeholders use historical fundamental indicators, such as Dr Ing's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dr Ing investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dr Ing's assets and liabilities are reflected in the revenues and expenses on Dr Ing's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dr Ing hcF. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in P911 Stock
Dr Ing financial ratios help investors to determine whether P911 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in P911 with respect to the benefits of owning Dr Ing security.